MedAvail To Report 2022 Third Quarter Financial Results on November 10, 2022

Rhea-AI Summary

MedAvail Holdings, Inc. (Nasdaq: MDVL) will disclose its third-quarter 2022 financial results on November 10, 2022, after market close. A webcast conference call will occur at 1:30 p.m. PT / 4:30 p.m. ET. Investors can register online via the 'Investor Relations' section of MedAvail's website for live access and subsequent replay. MedAvail, a technology-enabled pharmacy, enhances drug adherence through its robotic dispensing platform and services targeted at Medicare clinics.

Positive

• Scheduled financial results may indicate planned growth strategies.
• Technology-enabled pharmacy services potentially enhance patient outcomes.

Negative

• None.

MISSISSAUGA, Ontario & PHOENIX, Ariz.--(BUSINESS WIRE)-- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled pharmacy company, today announced it will report financial results for the third quarter of 2022 on Thursday, November 10, 2022, after market close. MedAvail management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

The conference call can be accessed by registering online for the live audio webcast on the “Investor Relations” section of MedAvail’s website at: https://investors.medavail.com. The webcast will be archived and available for replay after the event.

About MedAvail

MedAvail Holdings, Inc. (NASDAQ: MDVL) is a technology-enabled pharmacy organization, providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. MedAvail helps patients to optimize drug adherence, resulting in better health outcomes. Learn more at www.medavail.com.

About SpotRx

SpotRx places control of the pharmacy experience back in the hands of consumers. SpotRx is a telehealth platform that delivers remote pharmacist consultations through an on-site dispensing kiosk, supplemented with home delivery capability.

SOURCE MedAvail Holdings, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221027005313/en/

Investor Relations

Ji-Yon Yi

Gilmartin Group

ir@medavail.com

Source: MedAvail Holdings, Inc.

FAQ

When will MedAvail report its Q3 2022 financial results?

MedAvail will report its Q3 2022 financial results on November 10, 2022, after market close.

What time is the MedAvail Q3 2022 earnings call?

The MedAvail Q3 2022 earnings call is scheduled for 1:30 p.m. PT / 4:30 p.m. ET.

How can I access the MedAvail financial results conference call?

You can access the MedAvail conference call by registering online on the 'Investor Relations' section of their website.

What services does MedAvail provide?

MedAvail provides technology-enabled pharmacy services, including robotic dispensing and home delivery operations for Medicare clinics.